Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Kaliman J et al. | [Venous prostacycline synthesis and plasma thromboxane B2 after low-dose aspirin]. | 1983 | Wien. Klin. Wochenschr. | pmid:6359724 |
Wirthumer-Hoche C and Sinzinger H | [Protein binding of thromboxane--one of the sources of error in thromboxane determination]. | 1985 | Wien. Klin. Wochenschr. | pmid:3993037 |
Sinzinger H et al. | [Defects in the prostaglandin system. IX. Lipoxygenase defect of thrombocytes in a patient with polycythemia vera]. | 1990 | Wien. Klin. Wochenschr. | pmid:2107637 |
di Minno G et al. | The binding of fibrinogen to platelets in diabetes mellitus. | 1986 | Wien. Klin. Wochenschr. | pmid:3010580 |
Oettinger W et al. | [Thromboxane A2 and granulocyte elastase after severe trauma--relationship to complications and survival rates]. | 1989 | Wien. Klin. Wochenschr. | pmid:2609665 |
Gorczynska E et al. | [Effect of various stimulators on cyclooxygenase activity, platelet aggregation and TxB2 synthesis after using a platelet inhibitor (Aspro Clear) in vivo and in vitro]. | 1985 | Wiad. Lek. | pmid:3933184 |
Glushko LV et al. | [An evaluation of the efficacy of antiatherosclerotic agents based on a study of the peripheral blood monocytes]. | 1990 | Vrach Delo | pmid:2168603 |
Efimov VV and LadnyÄ AI | [Status of the prostacyclin and thromboxane system, lipid metabolism and lipid peroxidation processes in patients with coronary atherosclerosis]. | 1986 | Vrach Delo | pmid:3754994 |
Aliavi AL | [Thrombocyte function and the prostacyclin-thromboxane system in patients with acute myocardial infarct]. | 1988 | Vrach Delo | pmid:3293319 |
Bagdasarian A et al. | IVIG adverse reactions: potential role of cytokines and vasoactive substances. | 1998 | Vox Sang. | pmid:9501404 |
Jacobi K et al. | Plasma levels of eicosanoids after transfusion of intraoperatively salvaged blood. | 2000 | Vox Sang. | pmid:10729809 |
Bassalyk LS et al. | [The effect of indomethacin and leukinferon on the thromboxane B2 level in the blood plasma of patients with endometrial cancer in the perioperative period]. | 1992 | Vopr Onkol | pmid:1300754 |
Malý J et al. | [Changes in platelet function in patients with arterial hypertension]. | 1995 | Vnitr Lek | pmid:7571480 |
Spinarová L et al. | [Physical training in patients with chornic heart failure: haemodynamics, effects]. | 2001 | Vnitr Lek | pmid:15635849 |
Margolis JH et al. | The efficacy of dexamethasone and flunixin meglumine in treating endotoxin-induced changes in calves. | 1987 | Vet. Res. Commun. | pmid:3445446 |
Atroshi F et al. | Inflammation-related changes in cyclic AMP and cyclic GMP in bovine mastitis. | 1989 | Vet. Res. Commun. | pmid:2561035 |
Cheng Z et al. | Pharmacokinetic and pharmacodynamic studies on phenylbutazone and oxyphenbutazone in goats. | 1997 | Vet. Rec. | pmid:9123796 |
Friton GM et al. | Clinical and anti-inflammatory effects of treating endotoxin-challenged pigs with meloxicam. | 2006 | Vet. Rec. | pmid:17056651 |
Mustonen K et al. | Dose-response investigation of oral ketoprofen in pigs challenged with Escherichia coli endotoxin. | 2012 | Vet. Rec. | pmid:22735989 |
Taylor PM et al. | Pharmacodynamics and pharmacokinetics of flunixin in the cat: a preliminary study. | 1991 | Vet. Rec. | pmid:2035219 |